1 Study Coverage 1.1 Chinese Patent Medicine Product Introduction 1.2 Market by Type 1.2.1 Global Chinese Patent Medicine Market Size Growth Rate by Type 1.4.2 Syrup 1.4.3 Liquid 1.2.4 Tablet 1.2.5 Others 1.3 Market by Application 1.3.1 Global Chinese Patent Medicine Market Size Growth Rate by Application 1.3.2 Online Sales 1.3.3 Offline Sales 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Chinese Patent Medicine Sales Estimates and Forecasts 2016-2027 2.2 Global Chinese Patent Medicine Revenue Estimates and Forecasts 2016-2027 2.3 Global Chinese Patent Medicine Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Chinese Patent Medicine Regions by Sales 2.4.1 Global Top Chinese Patent Medicine Regions by Sales (2016-2021) 2.4.2 Global Top Chinese Patent Medicine Regions by Sales (2022-2027) 2.5 Global Top Chinese Patent Medicine Regions by Revenue 2.5.1 Global Top Chinese Patent Medicine Regions by Revenue (2016-2021) 2.5.2 Global Top Chinese Patent Medicine Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Chinese Patent Medicine Sales by Manufacturers 3.1.1 Global Top Chinese Patent Medicine Manufacturers by Sales (2016-2021) 3.1.2 Global Top Chinese Patent Medicine Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Chinese Patent Medicine Sales in 2020 3.2 Global Chinese Patent Medicine Revenue by Manufacturers 3.2.1 Global Top Chinese Patent Medicine Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Chinese Patent Medicine Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Chinese Patent Medicine Revenue in 2020 3.3 Global Chinese Patent Medicine Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Chinese Patent Medicine Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Chinese Patent Medicine Sales by Type 4.1.1 Global Chinese Patent Medicine Historical Sales by Type (2016-2021) 4.1.2 Global Chinese Patent Medicine Forecasted Sales by Type (2022-2027) 4.1.3 Global Chinese Patent Medicine Sales Market Share by Type (2016-2027) 4.2 Global Chinese Patent Medicine Revenue by Type 4.2.1 Global Chinese Patent Medicine Historical Revenue by Type (2016-2021) 4.2.2 Global Chinese Patent Medicine Forecasted Revenue by Type (2022-2027) 4.2.3 Global Chinese Patent Medicine Revenue Market Share by Type (2016-2027) 4.3 Global Chinese Patent Medicine Price by Type 4.3.1 Global Chinese Patent Medicine Price by Type (2016-2021) 4.3.2 Global Chinese Patent Medicine Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Chinese Patent Medicine Sales by Application 5.1.1 Global Chinese Patent Medicine Historical Sales by Application (2016-2021) 5.1.2 Global Chinese Patent Medicine Forecasted Sales by Application (2022-2027) 5.1.3 Global Chinese Patent Medicine Sales Market Share by Application (2016-2027) 5.2 Global Chinese Patent Medicine Revenue by Application 5.2.1 Global Chinese Patent Medicine Historical Revenue by Application (2016-2021) 5.2.2 Global Chinese Patent Medicine Forecasted Revenue by Application (2022-2027) 5.2.3 Global Chinese Patent Medicine Revenue Market Share by Application (2016-2027) 5.3 Global Chinese Patent Medicine Price by Application 5.3.1 Global Chinese Patent Medicine Price by Application (2016-2021) 5.3.2 Global Chinese Patent Medicine Price Forecast by Application (2022-2027) 6 North America 6.1 North America Chinese Patent Medicine Market Size by Type 6.1.1 North America Chinese Patent Medicine Sales by Type (2016-2027) 6.1.2 North America Chinese Patent Medicine Revenue by Type (2016-2027) 6.2 North America Chinese Patent Medicine Market Size by Application 6.2.1 North America Chinese Patent Medicine Sales by Application (2016-2027) 6.2.2 North America Chinese Patent Medicine Revenue by Application (2016-2027) 6.3 North America Chinese Patent Medicine Market Size by Country 6.3.1 North America Chinese Patent Medicine Sales by Country (2016-2027) 6.3.2 North America Chinese Patent Medicine Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Chinese Patent Medicine Market Size by Type 7.1.1 Europe Chinese Patent Medicine Sales by Type (2017-2027) 7.1.2 Europe Chinese Patent Medicine Revenue by Type (2017-2027) 7.2 Europe Chinese Patent Medicine Market Size by Application 7.2.1 Europe Chinese Patent Medicine Sales by Application (2017-2027) 7.2.2 Europe Chinese Patent Medicine Revenue by Application (2017-2027) 7.3 Europe Chinese Patent Medicine Market Size by Country 7.3.1 Europe Chinese Patent Medicine Sales by Country (2017-2027) 7.3.2 Europe Chinese Patent Medicine Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Chinese Patent Medicine Market Size by Type 8.1.1 Asia Pacific Chinese Patent Medicine Sales by Type (2018-2027) 8.1.2 Asia Pacific Chinese Patent Medicine Revenue by Type (2018-2027) 8.2 Asia Pacific Chinese Patent Medicine Market Size by Application 8.2.1 Asia Pacific Chinese Patent Medicine Sales by Application (2018-2027) 8.2.2 Asia Pacific Chinese Patent Medicine Revenue by Application (2018-2027) 8.3 Asia Pacific Chinese Patent Medicine Market Size by Region 8.3.1 Asia Pacific Chinese Patent Medicine Sales by Region (2018-2027) 8.3.2 Asia Pacific Chinese Patent Medicine Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Chinese Patent Medicine Market Size by Type 9.1.1 Latin America Chinese Patent Medicine Sales by Type (2019-2027) 9.1.2 Latin America Chinese Patent Medicine Revenue by Type (2019-2027) 9.2 Latin America Chinese Patent Medicine Market Size by Application 9.2.1 Latin America Chinese Patent Medicine Sales by Application (2019-2027) 9.2.2 Latin America Chinese Patent Medicine Revenue by Application (2019-2027) 9.3 Latin America Chinese Patent Medicine Market Size by Country 9.3.1 Latin America Chinese Patent Medicine Sales by Country (2019-2027) 9.3.2 Latin America Chinese Patent Medicine Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa Chinese Patent Medicine Market Size by Type 6.1.1 Middle East and Africa Chinese Patent Medicine Sales by Type (2016-2027) 6.1.2 Middle East and Africa Chinese Patent Medicine Revenue by Type (2016-2027) 6.2 Middle East and Africa Chinese Patent Medicine Market Size by Application 6.2.1 Middle East and Africa Chinese Patent Medicine Sales by Application (2016-2027) 6.2.2 Middle East and Africa Chinese Patent Medicine Revenue by Application (2016-2027) 6.3 Middle East and Africa Chinese Patent Medicine Market Size by Country 6.3.1 Middle East and Africa Chinese Patent Medicine Sales by Country (2016-2027) 6.3.2 Middle East and Africa Chinese Patent Medicine Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 U.A.E 11 Company Profiles 11.1 Shanghai Pharmaceutical (Group) Co., Ltd. 11.1.1 Shanghai Pharmaceutical (Group) Co., Ltd. Corporation Information 11.1.2 Shanghai Pharmaceutical (Group) Co., Ltd. Overview 11.1.3 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product Description 11.1.5 Shanghai Pharmaceutical (Group) Co., Ltd. Related Developments 11.2 China Pharmaceutical Group Corporation 11.2.1 China Pharmaceutical Group Corporation Corporation Information 11.2.2 China Pharmaceutical Group Corporation Overview 11.2.3 China Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 China Pharmaceutical Group Corporation Chinese Patent Medicine Product Description 11.2.5 China Pharmaceutical Group Corporation Related Developments 11.3 Guangzhou Pharmaceutical Group Co., Ltd. 11.3.1 Guangzhou Pharmaceutical Group Co., Ltd. Corporation Information 11.3.2 Guangzhou Pharmaceutical Group Co., Ltd. Overview 11.3.3 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Description 11.3.5 Guangzhou Pharmaceutical Group Co., Ltd. Related Developments 11.4 Tianjin Pharmaceutical Group Co., Ltd. 11.4.1 Tianjin Pharmaceutical Group Co., Ltd. Corporation Information 11.4.2 Tianjin Pharmaceutical Group Co., Ltd. Overview 11.4.3 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Description 11.4.5 Tianjin Pharmaceutical Group Co., Ltd. Related Developments 11.5 Harbin Pharmaceutical Group Co., Ltd 11.5.1 Harbin Pharmaceutical Group Co., Ltd Corporation Information 11.5.2 Harbin Pharmaceutical Group Co., Ltd Overview 11.5.3 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Product Description 11.5.5 Harbin Pharmaceutical Group Co., Ltd Related Developments 11.6 Nanjing Pharmaceutical Industry (Group) Co., Ltd. 11.6.1 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Corporation Information 11.6.2 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Overview 11.6.3 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Product Description 11.6.5 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Related Developments 11.7 North China Pharmaceutical Group Co., Ltd. 11.7.1 North China Pharmaceutical Group Co., Ltd. Corporation Information 11.7.2 North China Pharmaceutical Group Co., Ltd. Overview 11.7.3 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Description 11.7.5 North China Pharmaceutical Group Co., Ltd. Related Developments 11.8 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. 11.8.1 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Corporation Information 11.8.2 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Overview 11.8.3 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Description 11.8.5 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Related Developments 11.9 Taiji Group Co., Ltd. 11.9.1 Taiji Group Co., Ltd. Corporation Information 11.9.2 Taiji Group Co., Ltd. Overview 11.9.3 Taiji Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2016-2021) 11.9.4 Taiji Group Co., Ltd. Chinese Patent Medicine Product Description 11.9.5 Taiji Group Co., Ltd. Related Developments 11.10 Xinhualu Anti-Pharmaceutical Group Co., Ltd. 11.10.1 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Corporation Information 11.10.2 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Overview 11.10.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2016-2021) 11.10.4 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Description 11.10.5 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Related Developments 11.1 Shanghai Pharmaceutical (Group) Co., Ltd. 11.1.1 Shanghai Pharmaceutical (Group) Co., Ltd. Corporation Information 11.1.2 Shanghai Pharmaceutical (Group) Co., Ltd. Overview 11.1.3 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product Description 11.1.5 Shanghai Pharmaceutical (Group) Co., Ltd. Related Developments 11.12 Chongqing Pharmaceutical Co., Ltd 11.12.1 Chongqing Pharmaceutical Co., Ltd Corporation Information 11.12.2 Chongqing Pharmaceutical Co., Ltd Overview 11.12.3 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2016-2021) 11.12.4 Chongqing Pharmaceutical Co., Ltd Product Description 11.12.5 Chongqing Pharmaceutical Co., Ltd Related Developments 11.13 Hangzhou Huadong Pharmaceutical Group Co., Ltd. 11.13.1 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Corporation Information 11.13.2 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Overview 11.13.3 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2016-2021) 11.13.4 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Product Description 11.13.5 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Related Developments 11.14 Jiangxi Pharmaceutical Group Corporation 11.14.1 Jiangxi Pharmaceutical Group Corporation Corporation Information 11.14.2 Jiangxi Pharmaceutical Group Corporation Overview 11.14.3 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2016-2021) 11.14.4 Jiangxi Pharmaceutical Group Corporation Product Description 11.14.5 Jiangxi Pharmaceutical Group Corporation Related Developments 11.15 Shijiazhuang Pharmaceutical Group Co., Ltd. 11.15.1 Shijiazhuang Pharmaceutical Group Co., Ltd. Corporation Information 11.15.2 Shijiazhuang Pharmaceutical Group Co., Ltd. Overview 11.15.3 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2016-2021) 11.15.4 Shijiazhuang Pharmaceutical Group Co., Ltd. Product Description 11.15.5 Shijiazhuang Pharmaceutical Group Co., Ltd. Related Developments 11.16 Northeast Pharmaceutical Group Co., Ltd. 11.16.1 Northeast Pharmaceutical Group Co., Ltd. Corporation Information 11.16.2 Northeast Pharmaceutical Group Co., Ltd. Overview 11.16.3 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Price, Revenue and Gross Margin (2016-2021) 11.16.4 Northeast Pharmaceutical Group Co., Ltd. Product Description 11.16.5 Northeast Pharmaceutical Group Co., Ltd. Related Developments 12 Value Chain and Sales Channels Analysis 12.1 Chinese Patent Medicine Value Chain Analysis 12.2 Chinese Patent Medicine Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Chinese Patent Medicine Production Mode & Process 12.4 Chinese Patent Medicine Sales and Marketing 12.4.1 Chinese Patent Medicine Sales Channels 12.4.2 Chinese Patent Medicine Distributors 12.5 Chinese Patent Medicine Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Chinese Patent Medicine Industry Trends 13.2 Chinese Patent Medicine Market Drivers 13.3 Chinese Patent Medicine Market Challenges 13.4 Chinese Patent Medicine Market Restraints 14 Key Findings in The Global Chinese Patent Medicine Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Chinese Patent Medicine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Syrup Table 3. Major Manufacturers of Liquid Table 4. Major Manufacturers of Tablet Table 5. Major Manufacturers of Others Table 6. Global Chinese Patent Medicine Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 7. Global Chinese Patent Medicine Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 8. Global Chinese Patent Medicine Sales by Region (2016-2021) & (K MT) Table 9. Global Chinese Patent Medicine Sales Market Share by Region (2016-2021) Table 10. Global Chinese Patent Medicine Sales by Region (2016-2021) & (K MT) Table 11. Global Chinese Patent Medicine Sales Market Share by Region (2022-2027) Table 12. Global Chinese Patent Medicine Revenue by Region (2016-2021) & (US$ Million) Table 13. Global Chinese Patent Medicine Revenue Market Share by Region (2016-2021) Table 14. Global Chinese Patent Medicine Revenue by Region (2022-2027) & (US$ Million) Table 15. Global Chinese Patent Medicine Revenue Market Share by Region (2022-2027) Table 16. Global Chinese Patent Medicine Sales by Manufacturers (2016-2021) & (K MT) Table 17. Global Chinese Patent Medicine Sales Share by Manufacturers (2016-2021) Table 18. Global Chinese Patent Medicine Revenue by Manufacturers (2016-2021) & (US$ Million) Table 19. Global Chinese Patent Medicine Revenue Share by Manufacturers (2016-2021) Table 20. Chinese Patent Medicine Price by Manufacturers 2016-2021 (USD/MT) Table 21. Global Chinese Patent Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 22. Global Chinese Patent Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chinese Patent Medicine as of 2020) Table 23. Chinese Patent Medicine Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Chinese Patent Medicine Product Offered Table 25. Date of Manufacturers Enter into Chinese Patent Medicine Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Chinese Patent Medicine Sales by Type (2016-2021) & (K MT) Table 28. Global Chinese Patent Medicine Sales by Type (2022-2027) & (K MT) Table 29. Global Chinese Patent Medicine Sales Share by Type (2016-2021) Table 30. Global Chinese Patent Medicine Sales Share by Type (2022-2027) Table 31. Global Chinese Patent Medicine Revenue by Type (2016-2021) & (US$ Million) Table 32. Global Chinese Patent Medicine Revenue by Type (2022-2027) & (US$ Million) Table 33. Global Chinese Patent Medicine Revenue Share by Type (2016-2021) Table 34. Global Chinese Patent Medicine Revenue Share by Type (2022-2027) Table 35. Chinese Patent Medicine Price by Type (2016-2021) & (USD/MT) Table 36. Global Chinese Patent Medicine Price Forecast by Type (2022-2027) & (USD/MT) Table 37. Global Chinese Patent Medicine Sales by Application (2016-2021) & (K MT) Table 38. Global Chinese Patent Medicine Sales by Application (2022-2027) & (K MT) Table 39. Global Chinese Patent Medicine Sales Share by Application (2016-2021) Table 40. Global Chinese Patent Medicine Sales Share by Application (2022-2027) Table 41. Global Chinese Patent Medicine Revenue by Application (2016-2021) & (US$ Million) Table 42. Global Chinese Patent Medicine Revenue by Application (2022-2027) & (US$ Million) Table 43. Global Chinese Patent Medicine Revenue Share by Application (2016-2021) Table 44. Global Chinese Patent Medicine Revenue Share by Application (2022-2027) Table 45. Chinese Patent Medicine Price by Application (2016-2021) & (USD/MT) Table 46. Global Chinese Patent Medicine Price Forecast by Application (2022-2027) & (USD/MT) Table 47. North America Chinese Patent Medicine Sales by Type (2016-2021) & (K MT) Table 48. North America Chinese Patent Medicine Sales by Type (2022-2027) & (K MT) Table 49. North America Chinese Patent Medicine Revenue by Type (2016-2021) & (US$ Million) Table 50. North America Chinese Patent Medicine Revenue by Type (2022-2027) & (US$ Million) Table 51. North America Chinese Patent Medicine Sales by Application (2016-2021) & (K MT) Table 52. North America Chinese Patent Medicine Sales by Application (2022-2027) & (K MT) Table 53. North America Chinese Patent Medicine Revenue by Application (2016-2021) & (US$ Million) Table 54. North America Chinese Patent Medicine Revenue by Application (2022-2027) & (US$ Million) Table 55. North America Chinese Patent Medicine Sales by Country (2016-2021) & (K MT) Table 56. North America Chinese Patent Medicine Sales by Country (2022-2027) & (K MT) Table 57. North America Chinese Patent Medicine Revenue by Country (2016-2021) & (US$ Million) Table 58. North America Chinese Patent Medicine Revenue by Country (2022-2027) & (US$ Million) Table 59. Europe Chinese Patent Medicine Sales by Type (2016-2021) & (K MT) Table 60. Europe Chinese Patent Medicine Sales by Type (2022-2027) & (K MT) Table 61. Europe Chinese Patent Medicine Revenue by Type (2016-2021) & (US$ Million) Table 62. Europe Chinese Patent Medicine Revenue by Type (2022-2027) & (US$ Million) Table 63. Europe Chinese Patent Medicine Sales by Application (2016-2021) & (K MT) Table 64. Europe Chinese Patent Medicine Sales by Application (2022-2027) & (K MT) Table 65. Europe Chinese Patent Medicine Revenue by Application (2016-2021) & (US$ Million) Table 66. Europe Chinese Patent Medicine Revenue by Application (2022-2027) & (US$ Million) Table 67. Europe Chinese Patent Medicine Sales by Country (2016-2021) & (K MT) Table 68. Europe Chinese Patent Medicine Sales by Country (2022-2027) & (K MT) Table 69. Europe Chinese Patent Medicine Revenue by Country (2016-2021) & (US$ Million) Table 70. Europe Chinese Patent Medicine Revenue by Country (2022-2027) & (US$ Million) Table 71. Asia Pacific Chinese Patent Medicine Sales by Type (2016-2021) & (K MT) Table 72. Asia Pacific Chinese Patent Medicine Sales by Type (2022-2027) & (K MT) Table 73. Asia Pacific Chinese Patent Medicine Revenue by Type (2016-2021) & (US$ Million) Table 74. Asia Pacific Chinese Patent Medicine Revenue by Type (2022-2027) & (US$ Million) Table 75. Asia Pacific Chinese Patent Medicine Sales by Application (2016-2021) & (K MT) Table 76. Asia Pacific Chinese Patent Medicine Sales by Application (2022-2027) & (K MT) Table 77. Asia Pacific Chinese Patent Medicine Revenue by Application (2016-2021) & (US$ Million) Table 78. Asia Pacific Chinese Patent Medicine Revenue by Application (2022-2027) & (US$ Million) Table 79. Asia Pacific Chinese Patent Medicine Sales by Region (2016-2021) & (K MT) Table 80. Asia Pacific Chinese Patent Medicine Sales by Region (2022-2027) & (K MT) Table 81. Asia Pacific Chinese Patent Medicine Revenue by Region (2016-2021) & (US$ Million) Table 82. Asia Pacific Chinese Patent Medicine Revenue by Region (2022-2027) & (US$ Million) Table 83. Latin America Chinese Patent Medicine Sales by Type (2016-2021) & (K MT) Table 84. Latin America Chinese Patent Medicine Sales by Type (2022-2027) & (K MT) Table 85. Latin America Chinese Patent Medicine Revenue by Type (2016-2021) & (US$ Million) Table 86. Latin America Chinese Patent Medicine Revenue by Type (2022-2027) & (US$ Million) Table 87. Latin America Chinese Patent Medicine Sales by Application (2016-2021) & (K MT) Table 88. Latin America Chinese Patent Medicine Sales by Application (2022-2027) & (K MT) Table 89. Latin America Chinese Patent Medicine Revenue by Application (2016-2021) & (US$ Million) Table 90. Latin America Chinese Patent Medicine Revenue by Application (2022-2027) & (US$ Million) Table 91. Latin America Chinese Patent Medicine Sales by Country (2016-2021) & (K MT) Table 92. Latin America Chinese Patent Medicine Sales by Country (2022-2027) & (K MT) Table 93. Latin America Chinese Patent Medicine Revenue by Country (2016-2021) & (US$ Million) Table 94. Latin America Chinese Patent Medicine Revenue by Country (2022-2027) & (US$ Million) Table 95. Middle East and Africa Chinese Patent Medicine Sales by Type (2016-2021) & (K MT) Table 96. Middle East and Africa Chinese Patent Medicine Sales by Type (2022-2027) & (K MT) Table 97. Middle East and Africa Chinese Patent Medicine Revenue by Type (2016-2021) & (US$ Million) Table 98. Middle East and Africa Chinese Patent Medicine Revenue by Type (2022-2027) & (US$ Million) Table 99. Middle East and Africa Chinese Patent Medicine Sales by Application (2016-2021) & (K MT) Table 100. Middle East and Africa Chinese Patent Medicine Sales by Application (2022-2027) & (K MT) Table 101. Middle East and Africa Chinese Patent Medicine Revenue by Application (2016-2021) & (US$ Million) Table 102. Middle East and Africa Chinese Patent Medicine Revenue by Application (2022-2027) & (US$ Million) Table 103. Middle East and Africa Chinese Patent Medicine Sales by Country (2016-2021) & (K MT) Table 104. Middle East and Africa Chinese Patent Medicine Sales by Country (2022-2027) & (K MT) Table 105. Middle East and Africa Chinese Patent Medicine Revenue by Country (2016-2021) & (US$ Million) Table 106. Middle East and Africa Chinese Patent Medicine Revenue by Country (2022-2027) & (US$ Million) Table 107. Shanghai Pharmaceutical (Group) Co., Ltd. Corporation Information Table 108. Shanghai Pharmaceutical (Group) Co., Ltd. Description and Major Businesses Table 109. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 110. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product Table 111. Shanghai Pharmaceutical (Group) Co., Ltd. Recent Developments Table 112. China Pharmaceutical Group Corporation Corporation Information Table 113. China Pharmaceutical Group Corporation Description and Major Businesses Table 114. China Pharmaceutical Group Corporation Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 115. China Pharmaceutical Group Corporation Chinese Patent Medicine Product Table 116. China Pharmaceutical Group Corporation Recent Developments Table 117. Guangzhou Pharmaceutical Group Co., Ltd. Corporation Information Table 118. Guangzhou Pharmaceutical Group Co., Ltd. Description and Major Businesses Table 119. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 120. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Table 121. Guangzhou Pharmaceutical Group Co., Ltd. Recent Developments Table 122. Tianjin Pharmaceutical Group Co., Ltd. Corporation Information Table 123. Tianjin Pharmaceutical Group Co., Ltd. Description and Major Businesses Table 124. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 125. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Table 126. Tianjin Pharmaceutical Group Co., Ltd. Recent Developments Table 127. Harbin Pharmaceutical Group Co., Ltd Corporation Information Table 128. Harbin Pharmaceutical Group Co., Ltd Description and Major Businesses Table 129. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 130. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Product Table 131. Harbin Pharmaceutical Group Co., Ltd Recent Developments Table 132. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Corporation Information Table 133. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Description and Major Businesses Table 134. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 135. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Product Table 136. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Developments Table 137. North China Pharmaceutical Group Co., Ltd. Corporation Information Table 138. North China Pharmaceutical Group Co., Ltd. Description and Major Businesses Table 139. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 140. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Table 141. North China Pharmaceutical Group Co., Ltd. Recent Developments Table 142. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Corporation Information Table 143. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Description and Major Businesses Table 144. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 145. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Table 146. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Developments Table 147. Taiji Group Co., Ltd. Corporation Information Table 148. Taiji Group Co., Ltd. Description and Major Businesses Table 149. Taiji Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 150. Taiji Group Co., Ltd. Chinese Patent Medicine Product Table 151. Taiji Group Co., Ltd. Recent Developments Table 152. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Corporation Information Table 153. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Description and Major Businesses Table 154. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 155. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Table 156. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Developments Table 157. Nanjing Pharmaceutical Co., Ltd Corporation Information Table 158. Nanjing Pharmaceutical Co., Ltd Description and Major Businesses Table 159. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 160. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Table 161. Nanjing Pharmaceutical Co., Ltd Recent Developments Table 162. Chongqing Pharmaceutical Co., Ltd Corporation Information Table 163. Chongqing Pharmaceutical Co., Ltd Description and Major Businesses Table 164. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 165. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Table 166. Chongqing Pharmaceutical Co., Ltd Recent Developments Table 167. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Corporation Information Table 168. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Description and Major Businesses Table 169. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 170. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Table 171. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Developments Table 172. Jiangxi Pharmaceutical Group Corporation Corporation Information Table 173. Jiangxi Pharmaceutical Group Corporation Description and Major Businesses Table 174. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 175. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Product Table 176. Jiangxi Pharmaceutical Group Corporation Recent Developments Table 177. Shijiazhuang Pharmaceutical Group Co., Ltd. Corporation Information Table 178. Shijiazhuang Pharmaceutical Group Co., Ltd. Description and Major Businesses Table 179. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 180. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Table 181. Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Developments Table 182. Northeast Pharmaceutical Group Co., Ltd. Corporation Information Table 183. Northeast Pharmaceutical Group Co., Ltd. Description and Major Businesses Table 184. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021) Table 185. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Table 186. Northeast Pharmaceutical Group Co., Ltd. Recent Developments Table 187. Key Raw Materials Lists Table 188. Raw Materials Key Suppliers Lists Table 189. Chinese Patent Medicine Distributors List Table 190. Chinese Patent Medicine Customers List Table 191. Chinese Patent Medicine Market Trends Table 192. Chinese Patent Medicine Market Drivers Table 193. Chinese Patent Medicine Market Challenges Table 194. Chinese Patent Medicine Market Restraints Table 195. Research Programs/Design for This Report Table 196. Key Data Information from Secondary Sources Table 197. Key Data Information from Primary Sources List of Figures Figure 1. Chinese Patent Medicine Product Picture Figure 2. Global Chinese Patent Medicine Market Share by Type in 2020 & 2027 Figure 3. Syrup Product Picture Figure 4. Liquid Product Picture Figure 5. Tablet Product Picture Figure 6. Others Product Picture Figure 7. Global Chinese Patent Medicine Sales Market Share by Application in 2020 & 2027 Figure 8. Online Sales Figure 9. Offline Sales Figure 10. Chinese Patent Medicine Report Years Considered Figure 11. Global Chinese Patent Medicine Sales 2016-2027 (K MT) Figure 12. Global Chinese Patent Medicine Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Chinese Patent Medicine Revenue 2016-2027 (US$ Million) Figure 14. Global Chinese Patent Medicine Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 15. Global Chinese Patent Medicine Sales Market Share by Region (2016-2021) Figure 16. Global Chinese Patent Medicine Sales Market Share by Region (2022-2027) Figure 17. North America Chinese Patent Medicine Sales YoY (2016-2027) & (K MT) Figure 18. North America Chinese Patent Medicine Revenue YoY (2016-2027) & (US$ Million) Figure 19. Europe Chinese Patent Medicine Sales YoY (2016-2027) & (K MT) Figure 20. Europe Chinese Patent Medicine Revenue YoY (2016-2027) & (US$ Million) Figure 21. Asia-Pacific Chinese Patent Medicine Sales YoY (2016-2027) & (K MT) Figure 22. Asia-Pacific Chinese Patent Medicine Revenue YoY (2016-2027) & (US$ Million) Figure 23. Latin America Chinese Patent Medicine Sales YoY (2016-2027) & (K MT) Figure 24. Latin America Chinese Patent Medicine Revenue YoY (2016-2027) & (US$ Million) Figure 25. Middle East & Africa Chinese Patent Medicine Sales YoY (2016-2027) & (K MT) Figure 26. Middle East & Africa Chinese Patent Medicine Revenue YoY (2016-2027) & (US$ Million) Figure 27. The Top 10 and Top 5 Players Market Share by Chinese Patent Medicine Sales in 2020 Figure 28. The Top 10 and Top 5 Players Market Share by Chinese Patent Medicine Revenue in 2020 Figure 29. Chinese Patent Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 30. Global Chinese Patent Medicine Sales Market Share by Type (2016-2027) Figure 31. Global Chinese Patent Medicine Revenue Market Share by Type (2016-2027) Figure 32. Global Chinese Patent Medicine Sales Market Share by Application (2016-2027) Figure 33. Global Chinese Patent Medicine Revenue Market Share by Application (2016-2027) Figure 34. North America Chinese Patent Medicine Sales Market Share by Type (2016-2027) Figure 35. North America Chinese Patent Medicine Revenue Market Share by Type (2016-2027) Figure 36. North America Chinese Patent Medicine Sales Market Share by Application (2016-2027) Figure 37. North America Chinese Patent Medicine Revenue Market Share by Application (2016-2027) Figure 38. North America Chinese Patent Medicine Sales Share by Country (2016-2027) Figure 39. North America Chinese Patent Medicine Revenue Share by Country (2016-2027) Figure 40. U.S. Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 41. Canada Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 42. Europe Chinese Patent Medicine Sales Market Share by Type (2016-2027) Figure 43. Europe Chinese Patent Medicine Revenue Market Share by Type (2016-2027) Figure 44. Europe Chinese Patent Medicine Sales Market Share by Application (2016-2027) Figure 45. Europe Chinese Patent Medicine Revenue Market Share by Application (2016-2027) Figure 46. Europe Chinese Patent Medicine Sales Share by Country (2016-2027) Figure 47. Europe Chinese Patent Medicine Revenue Share by Country (2016-2027) Figure 48. Germany Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 49. France Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 50. U.K. Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 51. Italy Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 52. Russia Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 53. Asia Pacific Chinese Patent Medicine Sales Market Share by Type (2016-2027) Figure 54. Asia Pacific Chinese Patent Medicine Revenue Market Share by Type (2016-2027) Figure 55. Asia Pacific Chinese Patent Medicine Sales Market Share by Application (2016-2027) Figure 56. Asia Pacific Chinese Patent Medicine Revenue Market Share by Application (2016-2027) Figure 57. Asia Pacific Chinese Patent Medicine Sales Share by Region (2016-2027) Figure 58. Asia Pacific Chinese Patent Medicine Revenue Share by Region (2016-2027) Figure 59. China Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 60. Japan Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 61. South Korea Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 62. India Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 63. Australia Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 64. Taiwan Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 65. Indonesia Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 66. Thailand Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 67. Malaysia Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 68. Philippines Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 69. Latin America Chinese Patent Medicine Sales Market Share by Type (2016-2027) Figure 70. Latin America Chinese Patent Medicine Revenue Market Share by Type (2016-2027) Figure 71. Latin America Chinese Patent Medicine Sales Market Share by Application (2016-2027) Figure 72. Latin America Chinese Patent Medicine Revenue Market Share by Application (2016-2027) Figure 73. Latin America Chinese Patent Medicine Sales Share by Country (2016-2027) Figure 74. Latin America Chinese Patent Medicine Revenue Share by Country (2016-2027) Figure 75. Mexico Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 76. Brazil Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 77. Argentina Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 78. Middle East and Africa Chinese Patent Medicine Sales Market Share by Type (2016-2027) Figure 79. Middle East and Africa Chinese Patent Medicine Revenue Market Share by Type (2016-2027) Figure 80. Middle East and Africa Chinese Patent Medicine Sales Market Share by Application (2016-2027) Figure 81. Middle East and Africa Chinese Patent Medicine Revenue Market Share by Application (2016-2027) Figure 82. Middle East and Africa Chinese Patent Medicine Sales Share by Country (2016-2027) Figure 83. Middle East and Africa Chinese Patent Medicine Revenue Share by Country (2016-2027) Figure 84. Turkey Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 85. Saudi Arabia Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 86. U.A.E Chinese Patent Medicine Revenue (2016-2027) & (US$ Million) Figure 87. Chinese Patent Medicine Value Chain Figure 88. Chinese Patent Medicine Production Process Figure 89. Channels of Distribution Figure 90. Distributors Profiles Figure 91. Bottom-up and Top-down Approaches for This Report Figure 92. Data Triangulation Figure 93. Key Executives Interviewed

Shanghai Pharmaceutical (Group) Co., Ltd. China Pharmaceutical Group Corporation Guangzhou Pharmaceutical Group Co., Ltd. Tianjin Pharmaceutical Group Co., Ltd. Harbin Pharmaceutical Group Co., Ltd Nanjing Pharmaceutical Industry (Group) Co., Ltd. North China Pharmaceutical Group Co., Ltd. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Taiji Group Co., Ltd. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Nanjing Pharmaceutical Co., Ltd Chongqing Pharmaceutical Co., Ltd Hangzhou Huadong Pharmaceutical Group Co., Ltd. Jiangxi Pharmaceutical Group Corporation Shijiazhuang Pharmaceutical Group Co., Ltd. Northeast Pharmaceutical Group Co., Ltd.